Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1

@article{Orlova2017ExpandingTP,
  title={Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1},
  author={Elizaveta Orlova and Leila S. Sozaeva and Maria A. Kareva and Bergithe Eikeland Oftedal and Anette S.B. Wolff and Lars Ertesv{\aa}g Breivik and Ekaterina Y. Zakharova and Olga N. Ivanova and Olle K{\"a}mpe and Ivan I. Dedov and Per Morten Knappskog and Valentina A. Peterkova and Eystein Sverre Husebye},
  journal={The Journal of Clinical Endocrinology \& Metabolism},
  year={2017},
  volume={102},
  pages={3546–3556},
  url={https://api.semanticscholar.org/CorpusID:3822560}
}
The spectrum of phenotypes and AIRE mutation in APS‐1 has been expanded and Assay of interferon antibodies is a robust screening tool for APs‐1.
View on Wolters Kluwer
academic.oup.com
87 Citations
Highly Influential Citations
5
Background Citations
23
Methods Citations
2
Results Citations
3

Figures and Tables from this paper

87 Citations

Late-onset autoimmune polyendocrine syndrome type 1: a case report and literature review

A late-onset Chinese case who presented with symptoms of persistent tetany due to hypocalcemia is described, and next-generation sequencing identified a known homozygous AIRE mutation (p.R139X).

Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients

In Italy, APS-1 is a rare disorder presenting with the three major manifestations and associated with different AIRE gene mutations and other organ-specific autoantibodies are markers of clinical, subclinical or potential autoimmune conditions.

Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series

A comprehensive profile of Chinese patients with APS1 is provided, with less commonly observed features being observed in addition to more regularly seen manifestations, and different AIRE mutations that were observed have expanded the genetic spectrum.

Rapid whole-genome sequencing identifies a novel AIRE variant associated with autoimmune polyendocrine syndrome type 1

A 5-yr-old female who presented with symptoms of tetany due to hypocalcemia and was subsequently found to be secondary to hypoparathyroidism is reported, and compound heterozygous variants in AIRE in the proband are revealed.

A novel variant in AIRE causing a rare, non-classical autoimmune polyendocrine syndrome type 1

Under a regular follow-up and therapeutic adjustment of calcium, calcitriol, hormone replacement therapy and methylprednisolone, the endocrine function and clinical symptoms of the patient were notably improved and the known genetic and phenotypical spectra of APS-1 were expanded.

Autoimmune polyglandular syndrome type 1 with diabetes insipidus: a case report

This case suggests that diabetes insipidus is a rare component of APS-1 and expands the variety of mutations on AIRE gene.

Novel Gene Mutations Regulating Immune Responses in Autoimmune Polyglandular Syndrome With an Atypical Course

Exome sequencing revealed novel combination of mutations in the AIRE gene in atypical APS and imply that mutations in immune-related genes may modify the clinical manifestation of APS in AIRE-mutation carriers and contribute to the development of autoimmune pathology in non-AIRE carriers with atypICAL APS.

Late manifestation of autoimmune polyglandular syndrome type 1 with hypoparathyroidism and autoimmune thyroiditis

A clinical case of a patient with an atypical course of APS 1, in whom the first endocrine components (hypoparathyroidism and hypothyroidism) were diagnosed in adulthood, which highlights the phenotypic diversity of APS 1, and the difficulties in selecting therapy when several autoimmune endocrine diseases are combined.

Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence

A comprehensive review of the studies on APS1-associated AAD from initial case reports to the most recent scientific findings.

Leber congenital amaurosis as the initial and essential manifestation in a Chinese patient with autoimmune polyglandular syndrome Type 1

It is demonstrated that LCA could serve as a warning sign for APS-1 and a potential trigger of early screening, which might prevent life-threatening complications, in a 3-year-old boy with severely impaired vision.
...

42 References

Autoimmune Polyglandular Syndrome Type 1 in Russian Patients: Clinical Variants and Autoimmune Regulator Mutations

It is found that the R257X AIRE mutation is common in Russian APS-1 patients, and the majority of children with hypoparathyroidism and chronic mucocutaneous candidiasis were carriers of the AIRE mutations.

Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.

The single AIRE mutation, R139X, and the anti-IFN-ω and IFN-α autoantibodies are helpful for earlier diagnosis, especially when APS1 presents unusually.

Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.

The clinical features and the AIRE mutations are more diverse in the Norwegian population than previously thought, and some patients with APS I clinically resemble those from Finland and other European countries, but some have milder phenotypes.

A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1

Multiple presumable autoimmune manifestations, in particular hypoparathyroidism, CMC, and enamel hypoplasia, should prompt further diagnostic workup using autoantibody analyses (eg, interferon-ω) and AIRE sequencing to reveal APS1, even in adults.

Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.

NALP5 appears to be a tissue-specific autoantigen involved in hypoparathyroidism in patients with APS-1 and may be diagnostic for this prominent component of APs-1.

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I

This work presents a comprehensive overview on clinical characteristics, treatment and follow‐up based on personal experience and published studies for APS‐I.

Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

American APECED patients develop a diverse syndrome, with dramatic enrichment in organ-specific nonendocrine manifestations starting early in life, compared with European patients, and incorporation of these new manifestations into American diagnostic criteria would accelerate diagnosis by approximately 4 years and potentially prevent life-threatening endocrine complications.

Neurologic consequences of autoimmune polyglandular syndrome type 1

A patient with a previously undescribed autoimmune cerebellar degeneration occurring in association with APS-1 is reported with gait ataxia associated with band-like hyperintense signal abnormalities of both Cerebellar hemispheres and a unique antibody to cerebellAR Purkinje cells and brainstem neurons.

Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.

Precocious persistent antibodies found in patients with thymoma and/or myasthenia gravis show 98% or higher sensitivity and APS-I specificity and are thus a simpler diagnostic option than detecting AIRE mutations.

Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen

Autoantibodies to KCNRG, a protein mainly expressed in bronchial epithelium, are strongly associated with pulmonary involvement in APS-1, and these findings may facilitate the recognition, diagnosis, characterization, and understanding of the pulmonary manifestations of APs-1.